Articles

1. Benzodiazepines

   • Malcolm Lader

   Review Article 25 October 2012 Pages: 377 - 387

2. Combining Electroconvulsive Therapy and Drugs

   • Max Fink

   Review Article 25 October 2012 Pages: 370 - 376

3. Thyroid Function and Mood

   • Junichi Nomura

   Review Article 25 October 2012 Pages: 356 - 369

4. Chronic Fatigue Syndrome

   • David S. Bell
   • Paul T. Concemi
   • Arifulla Khan

   Review Article 25 October 2012 Pages: 348 - 355

5. Which Depressed Patients Should Receive Antidepressants?

   • Walter A. Brown
   • Arifulla Khan

   Practical Therapeutics 25 October 2012 Pages: 341 - 347

6. Erratum to: Childhood Epilepsy

   • Gilman Jamie T.
   • Duchowny Michael

   Erratum 25 October 2012 Pages: 340 - 340

7. Diagnosis and Pharmacological Treatment of Alcoholic Patients

   • Claudio A. Naranjo
   • Vural Ozdemir
   • Karen E. Bremner

   Practical Therapeutics 25 October 2012 Pages: 330 - 340

8. Efficacy of Lorenzo’s Oil in Adrenoleukodystrophy

   • Patrick Aubourg

   Leading Article 25 October 2012 Pages: 323 - 329

9. Managing Drug Dependence

   • Jack E. Henningfield
   • Edward G. Singleton

   Leading Article 25 October 2012 Pages: 317 - 322

10. Anxiolytic Potential of Benzodiazepine Receptor Partial Agonists

    • John Potokar
    • David J. Nutt

    Review Article 11 November 2012 Pages: 305 - 315

11. Biochemical Strategies for the Development of Antidepressants

    • B. E. Leonard

    Review Article 11 November 2012 Pages: 285 - 304

12. Use of Antiepileptic Drugs in Schizophrenia

    • Teruo Okuma

    Review Article 11 November 2012 Pages: 269 - 284

13. Stuttering

    • J. P. Brady
    • Moira Rynn

    Practical Therapeutics 11 November 2012 Pages: 263 - 268

14. Outpatient Care in Schizophrenia

    • Ullrich Meise
    • Wulf Rössler
    • W. Wolfgang Fleischhacker

    Practical Therapeutics 11 November 2012 Pages: 254 - 262

15. Diagnosis and Optimum Treatment of Migraine

    • Peter J. Goadsby

    Practical Therapeutics 11 November 2012 Pages: 245 - 253

16. Inflamination and Alzheimer’s Disease

    • Joseph Rogers

    Leading Article 11 November 2012 Pages: 241 - 244

17. Velnacrine in Alzheimer’s Disease

    • Karen L. Goa
    • Andrew Fitton

    Drug Evaluation 11 November 2012 Pages: 232 - 240

18. The Fluoxetine and Suicide Controversy

    • David Healy

    Adverse Effects 11 November 2012 Pages: 223 - 231

19. The Therapeutic Role of Gangliosides in Neurological Disorders

    • Jay S. Schneider

    Drug Therapy 11 November 2012 Pages: 213 - 222

20. Advances in the Treatment of Anorexia Nervosa and Bulimia Nervosa

    • Sidney H. Kennedy
    • David S. Goldbloom

    Drug Therapy 11 November 2012 Pages: 201 - 212

21. Clinical Features and Drug Treatment of Psychodermatological Disorders

    • Myriam Van Moffaert

    Practical Therapeutics 11 November 2012 Pages: 193 - 200

22. Childhood Epilepsy

    • Jamie T. Gilman
    • Michael Duchowny

    Practical Therapeutics 11 November 2012 Pages: 180 - 192

23. Clinical Potential of Catechol-OMethyltransferase (COMT) Inhibitors as Adjuvants in Parkinson’s Disease

    • Pekka T. Ménnistó

    Leading Article 11 November 2012 Pages: 172 - 179

24. Problems in the Assessment of Potential Antiepileptic Drugs

    • Mervyn J. Eadie

    Leading Article 11 November 2012 Pages: 167 - 171

25. The Role of Cholinesterase Inhibitors in Alzheimer’s Disease

    • Peter P. Lamy

    Drug Therapy 25 October 2012 Pages: 146 - 165

26. Risk Factors Associated with Ischaemic Stroke

    • Karl Zeiler
    • Harold Kollegger

    Clinical Concepts 25 October 2012 Pages: 132 - 145

27. Differential Diagnosis and Drug Treatment of Panic Disorder, Anxiety and Depression

    • Graham D. Burrows
    • Fiona K. Judd
    • Trevor R. Norman

    Practical Therapeutics 25 October 2012 Pages: 119 - 131

28. Options for the Treatment of Negative Symptoms of Schizophrenia

    • Ian Coffey

    Practical Therapeutics 25 October 2012 Pages: 107 - 118

29. Attention Deficit Hyperactivity Disorder

    • Candace S. Brown
    • Stephen C. Cooke

    Practical Therapeutics 25 October 2012 Pages: 95 - 106

30. Age-Associated Memory Impairment

    • John T. O’Brien

    Leading Article 25 October 2012 Pages: 89 - 94

31. Fluvoxamine

    • Katharine J. Palmer
    • Paul Benfield

    Drug Evaluation 18 November 2012 Pages: 57 - 87

32. Potential of Neuroprotective Therapy in Parkinson’s Disease

    • Yoshikuni Mizuno
    • Hideo Mori
    • Tomoyoshi Kondo

    Drug Therapy Review 18 November 2012 Pages: 45 - 56

33. Management of Status Epilepticus in Adults

    • Jürgen Bauer
    • Christian E. Elger

    Practical Therapeutics 18 November 2012 Pages: 26 - 44

34. Pharmacological Strategies for Preventing Suicidal Behaviour

    • Fabrizio Schifano

    Practical Therapeutics 18 November 2012 Pages: 16 - 25

35. 5-HT₄ Receptors

    • Jóel Bockaert
    • Hervé Ansanay
    • Aline Dumuis

    Leading Article 18 November 2012 Pages: 6 - 15

36. The Dopamine D2 Receptor Gene (DRD2) and Neuropsychiatric Disorders

    • David E. Comings

    Leading Article 18 November 2012 Pages: 1 - 5